Form 4 for GILD Gilead Sciences
Accepted 2024-09-11 00:00:00 ET · period of report 2024-09-10 · accession 0001127602-24-023819 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-11 | 2024-09-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +10.3K | 500.7K | +2% | — |
| D | 2024-09-11 | 2024-09-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $81.44 | -4,749 | 496.0K | -0.9% | -$386.8K |
| D | 2024-09-11 | 2024-09-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | -10.3K | 115.3K | -8% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-10 | M | A | 10,295 | — | 500,744 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2024-09-10 | F | D | 4,749 | $81.44 | 495,995 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-09-10 | M | D | 10,295 | — | 115,272 | D | — · — to — | 10,295 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |